feed,title,long_url,short_url
Benzinga,Gracell Biotech's Multiple Myeloma Candidate Shows 100% Response Rate In Newly Diagnosed Candidates,https://benzinga.com/general/biotech/22/12/30041824/gracell-biotechs-multiple-myeloma-candidate-shows-100-response-rate-in-newly-diagnosed-candidates,https://da.gd/YvtAje
Benzinga,"Bitcoin Holder MicroStrategy, SurgePays And 3 Other Short Squeeze Stocks That Could Soar This Week",https://benzinga.com/markets/cryptocurrency/22/12/30042438/bitcoin-holder-microstrategy-surgepays-and-3-other-short-squeeze-stocks-that-could-soar-th,https://da.gd/KfW5P
